Kura Oncology Inc. KURA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Kura Oncology Inc. is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of precision medicines for cancer treatment. It specializes in novel therapies that selectively target cancer cells, addressing areas with significant unmet medical needs such as HRAS mutant soli…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees260
TickerKURA
Statistics
Market Cap$845.5M
Revenue (TTM)$67.5M
Net Income-$278.7M
Net Margin-412.9%
EPS$-3.35
P/E-2.78
P/S10.98
P/B7.29
EV/EBITDA-0.68
ROE-124.7%
Dividend Yield—
Price$9.53
Data: Twelve Data · Revenue = mcap / P/S